posted on 2022-03-09, 22:29authored byChristoph Müller, Jakob Gleixner, Maris-Johanna Tahk, Sergei Kopanchuk, Tõnis Laasfeld, Michael Weinhart, Dieter Schollmeyer, Martin U. Betschart, Steffen Lüdeke, Pierre Koch, Ago Rinken, Max Keller
The recent crystallization of the
neuropeptide Y Y1 receptor
(Y1R) in complex with the argininamide-type Y1R selective antagonist UR-MK299 (2) opened up a new
approach toward structure-based design of nonpeptidic Y1R ligands. We designed novel fluorescent probes showing excellent
Y1R selectivity and, in contrast to previously described
fluorescent Y1R ligands, considerably higher (∼100-fold)
binding affinity. This was achieved through the attachment of different
fluorescent dyes to the diphenylacetyl moiety in 2 via
an amine-functionalized linker. The fluorescent ligands exhibited
picomolar Y1R binding affinities (pKi values of 9.36–9.95) and proved to be Y1R antagonists, as validated in a Fura-2 calcium assay. The versatile
applicability of the probes as tool compounds was demonstrated by
flow cytometry- and fluorescence anisotropy-based Y1R binding
studies (saturation and competition binding and association and dissociation
kinetics) as well as by widefield and total internal reflection fluorescence
(TIRF) microscopy of live tumor cells, revealing that fluorescence
was mainly localized at the plasma membrane.